Different Approaches for Obtaining Antibodies from Human B Cells

Author(s): Marcus R. Duvall, Ryan N. Fiorini

Journal Name: Current Drug Discovery Technologies

Volume 11 , Issue 1 , 2014


Become EABM
Become Reviewer
Call for Editor

Abstract:

Antibodies have emerged as powerful therapeutics effective for treating a number of human conditions and diseases. While early successes utilized small animals to generate therapeutic antibodies, human antibodies are now preferred in order to limit anti-antibody immune responses. Antibodies with human amino acid sequences can be generated in a number of ways, such as humanizing antibodies from other species or expressing human antibodies in transgenic animals. This review focuses on methods for obtaining antibodies directly from human B cells. These methods use both antigen exposed and non-exposed (“naïve”) humans as B cell sources, and apply various technologies to isolate desired antibodies; including cell line generation, single cell isolation, display technologies, and B cell library generation.

Keywords: Antibody engineering, antibody libraries, display technologies, high-throughput screening, human monoclonal antibodies, human B cell.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 11
ISSUE: 1
Year: 2014
Page: [41 - 47]
Pages: 7
DOI: 10.2174/1570163811666140121154649

Article Metrics

PDF: 96